mhurhangee/patent-ind-claim-en huggingface dataset:
A method for controlling a communication of a first communicating device to a second communicating device over a communication network , the method comprises: monitoring , by a network device , data traffic to the communication network from the first communication device, the network device is arranged to monitor the data traffic through a port of a network node, the network node residing in the communication channel in which the data traffic is conveyed and the port of the network node is arranged to mirror the data traffic to the network device , in response to local detection of at least one predetermined piece of information in at least one data frame in the data traffic generating , by the network device , an acknowledgement complying with a communication protocol used for the communication, and transmitting, by the network device , the generated acknowledgement to the first communication device for indicating a delivery of the data traffic to the second communicating device. monitoring , by a network device , data traffic to the communication network from the first communication device, the network device is arranged to monitor the data traffic through a port of a network node, the network node residing in the communication channel in which the data traffic is conveyed and the port of the network node is arranged to mirror the data traffic to the network device , in response to local detection of at least one predetermined piece of information in at least one data frame in the data traffic generating , by the network device , an acknowledgement complying with a communication protocol used for the communication, and transmitting, by the network device , the generated acknowledgement to the first communication device for indicating a delivery of the data traffic to the second communicating device.
A process for the preparation of polyol esters, namely polyglycerol esters of 3-hydroxybutyric acid (beta-hydroxybutyric acid, BHB or 3-BHB), wherein at least one compound of the general formula (I) CH 3 -CH(OH)-CH 2 -C(O)OR 1 (I) where, in the general formula (I), the radical R 1 is hydrogen or a C 1 -C 4 -alkyl, in particular a C 1 -C 4 -alkyl, preferably methyl or ethyl, particularly preferably ethyl, is reacted with at least one polyglycerol of the general formula (IIb) HO-CH 2 -CH(OH)-CH 2 -[O-CH 2 -CH(OH)-CH 2 ] p -OH (IIb) in which general formula (IIb) the variable p represents an integer from 1 to 4, in particular 1 or 2, preferably 1, wherein the reaction is carried out in the absence of solvents and/or without any solvent, and wherein the reaction is carried out in the presence of a catalyst, such that one or more 3-hydroxybutyric acid polyol esters (III), namely 3-hydroxybutyric acid polyglycerol esters, are obtained as reaction product, wherein the reaction simultaneously yields the compound according to the general formula (IV) R 1 -OH (IV) in which general formula (IV) the radical R 1 represents hydrogen or a C 1 -C 4 -alkyl, in particular a C 1 -C 4 -alkyl, preferably methyl or ethyl, particularly preferably ethyl, the compound according to the general formula (IV) being continuously withdrawn from the reaction. wherein at least one compound of the general formula (I) CH 3 -CH(OH)-CH 2 -C(O)OR 1 (I) where, in the general formula (I), the radical R 1 is hydrogen or a C 1 -C 4 -alkyl, in particular a C 1 -C 4 -alkyl, preferably methyl or ethyl, particularly preferably ethyl, is reacted with at least one polyglycerol of the general formula (IIb) HO-CH 2 -CH(OH)-CH 2 -[O-CH 2 -CH(OH)-CH 2 ] p -OH (IIb) in which general formula (IIb) the variable p represents an integer from 1 to 4, in particular 1 or 2, preferably 1, wherein the reaction is carried out in the absence of solvents and/or without any solvent, and wherein the reaction is carried out in the presence of a catalyst, such that one or more 3-hydroxybutyric acid polyol esters (III), namely 3-hydroxybutyric acid polyglycerol esters, are obtained as reaction product, wherein the reaction simultaneously yields the compound according to the general formula (IV) R 1 -OH (IV) in which general formula (IV) the radical R 1 represents hydrogen or a C 1 -C 4 -alkyl, in particular a C 1 -C 4 -alkyl, preferably methyl or ethyl, particularly preferably ethyl, the compound according to the general formula (IV) being continuously withdrawn from the reaction.
An organic polymerizable composition for producing a molded polymeric article, the composition comprising a mold release agent comprised of ionic fluoride and/or ionic fluoride precursor present in an amount sufficient to effect at least partial demolding of the polymeric article from a mold, wherein the ionic fluoride is present in an amount ranging from 20 to 5000 ppm; wherein the mold release agent is selected from the group consisting of ammonium fluoride, potassium fluoride, cesium fluoride, tin (II) fluoride, sodium tetrafluoroborate, tetrabutyl ammonium fluoride (trihydrate), and mixtures thereof; and wherein the composition further comprises a mold release agent which does not comprise ionic fluoride. wherein the ionic fluoride is present in an amount ranging from 20 to 5000 ppm; wherein the mold release agent is selected from the group consisting of ammonium fluoride, potassium fluoride, cesium fluoride, tin (II) fluoride, sodium tetrafluoroborate, tetrabutyl ammonium fluoride (trihydrate), and mixtures thereof; and wherein the composition further comprises a mold release agent which does not comprise ionic fluoride.
A monoclonal antibody that binds a KIR3DL2 polypeptide comprising an amino acid sequence of SEQ ID NO: 1, wherein said antibody does not bind to a KIR3DL1 polypeptide comprising an amino acid sequence of SEQ ID NO: 169, and wherein said antibody is not internalized into KIR3DL2-expressing cells, wherein said antibody has reduced binding to a mutant KIR3DL2 polypeptide having amino acid mutations I60N and G62S and/or to a mutant KIR3DL2 polypeptide having amino acid mutations P14S, S15A and H23S, relative to binding between the antibody and a wild-type KIR3DL2 polypeptide of SEQ ID NO: 1, wherein said antibody competes for binding to a KIR3DL2 polypeptide with an antibody having respectively a VH and VL region of SEQ ID NOS: 13 and 14.
Electronic apparatus , in particular controller for a motor vehicle, wherein the apparatus has electronic components comprising at least one circuit carrier and an electrolytic capacitor connected to the circuit carrier , wherein at least some of the components are embedded in each case at least partially in a moulding compound , characterized in that the apparatus has a container with a container opening and the electrolytic capacitor is accommodated in the container , wherein the container is filled with an, in particular low-viscosity, potting compound , so that the electrolytic capacitor is surrounded by the potting compound and a protective casing for the electrolytic capacitor is formed when the components are embedded in the moulding compound , wherein the moulding compound adjoins the container and/or the potting compound in the region of the container opening in a materially bonded and/or cohesive manner.
Bathtub comprising a splash guard wall , wherein at least one side surface of the bathtub is at least partially covered with a skirt and the skirt extends in height up to a region of a bathtub rim of the bathtub , characterized in that a retaining profile is arranged on the bathtub and the retaining profile holds the splash guard wall and in that the splash guard wall and the skirt form a flush outer wall , wherein the outer wall laterally adjoins the bathtub rim and at least partially overlaps the bathtub rim and extends a certain height above the bathtub rim and a certain height below the bathtub rim .
A method for controlling a spot welding arrangement , the method comprising the steps of: - moving a welding tip portion of the spot welding arrangement between a first and a second position by applying a force to the welding tip portion ; - determining a distance moved between the first and second positions; - determining a type of welding yoke , from a plurality of predefined welding yokes, connected to the rest of the spot welding arrangement based on the determined distance and the applied force, the spot welding arrangement comprising a control unit comprising welding yoke data for each of the plurality of predefined welding yokes; and - controlling settings of the spot welding arrangement based on the welding yoke connected to the spot welding arrangement. - moving a welding tip portion of the spot welding arrangement between a first and a second position by applying a force to the welding tip portion ; - determining a distance moved between the first and second positions; - determining a type of welding yoke , from a plurality of predefined welding yokes, connected to the rest of the spot welding arrangement based on the determined distance and the applied force, the spot welding arrangement comprising a control unit comprising welding yoke data for each of the plurality of predefined welding yokes; and - controlling settings of the spot welding arrangement based on the welding yoke connected to the spot welding arrangement.
A sanitizing rinse additive composition comprising: 1 wt-% to 40 wt-% of a C 1 -C 22 peroxycarboxylic acid; 1 wt-% to 80 wt-% of a C 1 -C 22 carboxylic acid; 1 wt-% to 80 wt-% of hydrogen peroxide; and 10 wt-% to 50 wt-% of a nonionic defoaming and wetting surfactant(s); wherein the composition is a low odor concentrate having less than 2 wt-% peroxyacetic acid, wherein the nonionic defoaming surfactant is an alkyl-ethylene oxide-propylene oxide copolymer surfactant and wherein the nonionic wetting surfactant is an alcohol ethoxylate according to the following structure R-O-(CH 2 CH 2 O) n -H, wherein R is a C 1 -C 12 alkyl group and n is an integer in the range of 1 to 100 and/or an alkyl ethoxylate having the structure Alkyl-(EO)n-EOR, wherein R = alkyl (60-80%), R = H (20-40%) and n is an integer in the range from 1 to 20; wherein the composition when diluted from 0.01% weight/volume to 0.02% weight/volume provides at least a 5 log reduction in pathogenic organisms at a temperature of at least about 37.77°C (100°F) and the diluted composition has a pH greater than 5. 1 wt-% to 40 wt-% of a C 1 -C 22 peroxycarboxylic acid; 1 wt-% to 80 wt-% of a C 1 -C 22 carboxylic acid; 1 wt-% to 80 wt-% of hydrogen peroxide; and 10 wt-% to 50 wt-% of a nonionic defoaming and wetting surfactant(s); wherein the composition is a low odor concentrate having less than 2 wt-% peroxyacetic acid, wherein the nonionic defoaming surfactant is an alkyl-ethylene oxide-propylene oxide copolymer surfactant and wherein the nonionic wetting surfactant is an alcohol ethoxylate according to the following structure R-O-(CH 2 CH 2 O) n -H, wherein R is a C 1 -C 12 alkyl group and n is an integer in the range of 1 to 100 and/or an alkyl ethoxylate having the structure Alkyl-(EO)n-EOR, wherein R = alkyl (60-80%), R = H (20-40%) and n is an integer in the range from 1 to 20; wherein the composition when diluted from 0.01% weight/volume to 0.02% weight/volume provides at least a 5 log reduction in pathogenic organisms at a temperature of at least about 37.77°C (100°F) and the diluted composition has a pH greater than 5.
A chimeric antigen receptor (CAR) comprising: a) an extracellular domain that comprises an anti-sialyl Tn (STn) antibody or antigen binding fragment thereof that binds one or more epitopes of an STn antigen expressed on a glycoprotein, wherein the anti-STn antibody or antigen binding fragment thereof comprises a variable light chain sequence comprising CDRL1-CDRL3 sequences set forth in SEQ ID NOs: 9-11, and a variable heavy chain sequence comprising CDRH1-CDRH3 sequences set forth in SEQ ID NOs: 12-14; b) a CD8α hinge domain; c) a CD8α transmembrane domain; d) a CD137 intracellular co-stimulatory signaling domain; and e) a CD3ζ primary signaling domain. a) an extracellular domain that comprises an anti-sialyl Tn (STn) antibody or antigen binding fragment thereof that binds one or more epitopes of an STn antigen expressed on a glycoprotein, wherein the anti-STn antibody or antigen binding fragment thereof comprises a variable light chain sequence comprising CDRL1-CDRL3 sequences set forth in SEQ ID NOs: 9-11, and a variable heavy chain sequence comprising CDRH1-CDRH3 sequences set forth in SEQ ID NOs: 12-14; b) a CD8α hinge domain; c) a CD8α transmembrane domain; d) a CD137 intracellular co-stimulatory signaling domain; and e) a CD3ζ primary signaling domain.
Electrotherapy device as a hand-held device for applying an electrical therapy pulse to the skin of a patient, comprising: - an oscillating circuit having an output capacitor for applying the electrical therapy pulse to the skin of a patient and an oscillating circuit coil connected to the output capacitor , - a charging coil magnetically coupled to the oscillating circuit coil for charging the oscillating circuit coil , and - an energizing device for energizing the charging coil with a charging current , characterized in that the energizing device comprises adjusting means with which the charging current can be adjusted in at least three, in particular at least four, different levels. - an oscillating circuit having an output capacitor for applying the electrical therapy pulse to the skin of a patient and an oscillating circuit coil connected to the output capacitor , - a charging coil magnetically coupled to the oscillating circuit coil for charging the oscillating circuit coil , and - an energizing device for energizing the charging coil with a charging current ,
A polymer-based ocular insert for drug delivery by noninvasive insertion into the upper or lower fornix conjunctiva of the eye, where the ocular insert has a spherical or spherical dome shape or hemispherical shape, comprises at least one polymeric layer with a drug core and allows the sustained release of at least one drug, characterized in that the drug core comprises a first drug and is configured to release such first drug at a first rate and the at least one polymeric layer comprises a second drug and is configured to release such second drug at a second rate, wherein the drug core and the at least one polymeric layer are configured to completely release the first and second drugs such that the first and second release rates are different, in that the at least one polymeric layer comprises a copolymer of polycaprolactone (PCL) and polyethylene glycol (PEG); and wherein the molecular weight of PCL varies from 500 up to 30, 000 and the molecular weight of PEG varies from 200 up to 40,000. the drug core comprises a first drug and is configured to release such first drug at a first rate and the at least one polymeric layer comprises a second drug and is configured to release such second drug at a second rate, wherein the drug core and the at least one polymeric layer are configured to completely release the first and second drugs such that the first and second release rates are different, in that the at least one polymeric layer comprises a copolymer of polycaprolactone (PCL) and polyethylene glycol (PEG); and wherein the molecular weight of PCL varies from 500 up to 30, 000 and the molecular weight of PEG varies from 200 up to 40,000.
Concrete structure characterized by comprising the following composition in percentage by weight of components relative to the total weight of the composition: - Portland cement - 5 to 40%; - Fly Ash and/or Pozzolans - 5 to 40%; - Calcium sulphate - 0.1 to 15%; - Silica and/or dolomitic/basalt sand - 15 to 40%; - Dolomitic and/or basaltic gravel - 25 to 60%; - Rubber Agglomerate and/or Cork Agglomerate and/or Rubber Waste and/or Cork Waste -1 to 15%; - Steel fibers and/or carbon fiber - 0.1 to 5%; - Superplasticizer - 0.1 to 3%. - Portland cement - 5 to 40%; - Fly Ash and/or Pozzolans - 5 to 40%; - Calcium sulphate - 0.1 to 15%; - Silica and/or dolomitic/basalt sand - 15 to 40%; - Dolomitic and/or basaltic gravel - 25 to 60%; - Rubber Agglomerate and/or Cork Agglomerate and/or Rubber Waste and/or Cork Waste -1 to 15%; - Steel fibers and/or carbon fiber - 0.1 to 5%; - Superplasticizer - 0.1 to 3%.
Method of manufacturing a trench oxide in a trench for a gate structure in a semiconductor substrate, the method comprising: generating the trench in the semiconductor substrate ; generating an oxide layer over opposing sidewalls of the trench; damaging at least a portion of the oxide layer at at least one of the opposing sidewalls by ion implantation; coating the oxide layer with an etching mask ; generating at least one opening in the etching mask adjacent to the at least one of the opposing sidewalls ; and partly removing the oxide layer by etching the oxide layer beneath the etching mask down to an etching depth at the at least one of the opposing sidewalls by introducing an etching agent into the opening . generating the trench in the semiconductor substrate ; generating an oxide layer over opposing sidewalls of the trench; damaging at least a portion of the oxide layer at at least one of the opposing sidewalls by ion implantation; coating the oxide layer with an etching mask ; generating at least one opening in the etching mask adjacent to the at least one of the opposing sidewalls ; and partly removing the oxide layer by etching the oxide layer beneath the etching mask down to an etching depth at the at least one of the opposing sidewalls by introducing an etching agent into the opening .
Process for the treatment of lyocell fibres, comprising the step of contacting the fibre with at least one treatment medium, at least one treatment medium containing an amount of a crosslinking agent, wherein the cross-linking agent is capable of crosslinking cellulose under alkaline conditions and has a solubility in water at 20°C of 20 g/l or less, and further comprising the step of treating the fibre with the cross-linking agent under alkaline conditions, characterized in that in the step of contacting the fibre the cross-linking agent is present in the form of a suspension or in solid form.
Tuneable hydrogen sensing device allowing controlled and reliable, hysteresis free, measurement of an amount of hydrogen comprising: a hydrogen sensing material , the hydrogen sensing material comprising an alloy M 1-y A x B z , wherein y=x+z, and wherein B is optionally present, wherein the metal M is selected from Group V elements, and at least one alloying element A being selected from elements with a cubic unit cell, such as Pd, Ni, Pt, Ru, Rh, and combinations thereof, wherein hydrogenation of the hydrogen sensing material is tuneable by changing an amount x of the at least one alloying element in the alloy M 1-y A x B z , wherein the at least one alloying element A is present in an amount of x=0.01-35 atom%; and a hydrogen sensing material read-out system , wherein the hydrogen sensing material read-out system is selected from optical read-out systems, dielectric read-out systems, electro-magnetic read-out systems, such as an electrical current detector, an electrical voltage detector, an electrical resistance detector, and a transistor, and combinations thereof. a hydrogen sensing material , the hydrogen sensing material comprising an alloy M 1-y A x B z , wherein y=x+z, and wherein B is optionally present, wherein the metal M is selected from Group V elements, and at least one alloying element A being selected from elements with a cubic unit cell, such as Pd, Ni, Pt, Ru, Rh, and combinations thereof, wherein hydrogenation of the hydrogen sensing material is tuneable by changing an amount x of the at least one alloying element in the alloy M 1-y A x B z , wherein the at least one alloying element A is present in an amount of x=0.01-35 atom%; and a hydrogen sensing material read-out system , wherein the hydrogen sensing material read-out system is selected from optical read-out systems, dielectric read-out systems, electro-magnetic read-out systems, such as an electrical current detector, an electrical voltage detector, an electrical resistance detector, and a transistor, and combinations thereof.
A method comprising: receiving audio data comprising speech at a first client device executing an application in an artificial reality environment, wherein the first client device is associated with a speaking user; determining whether an object associated with the speaking user is within a field of view of a listening user of a second client device executing the application; modifying the audio data based at least in part on a set of rules and whether the object associated with the speaking user is within the field of view of the listening user; and communicating the modified audio data to the listening user of the second client device. receiving audio data comprising speech at a first client device executing an application in an artificial reality environment, wherein the first client device is associated with a speaking user; determining whether an object associated with the speaking user is within a field of view of a listening user of a second client device executing the application; modifying the audio data based at least in part on a set of rules and whether the object associated with the speaking user is within the field of view of the listening user; and communicating the modified audio data to the listening user of the second client device.
Apparatus for servicing an elongate structure , comprising a bypass module connected in series along the structure between a first drive module and a second drive and/or servicing module , each of which may be selectively closed around the structure or opened to enable removal from the structure , wherein the bypass module is actuable to move the first and second modules relative to each other in a perpendicular direction to the elongate structure towards or away from the elongate structure , so that the second module is moved in the perpendicular direction away from the structure while the first module is closed around the structure and the first module is drivable along the elongate structure so as to drive the second module past an obstruction on the elongate structure .